/>
Jan 152021
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

–  BELGIUM, Mont-Saint-Guibert –  Celyad Oncology SA (EBR: CYAD | NASDAQ: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced the appointment of Dr. Marina Udier, Ph.D. to its Board of Directors. “I am very ...

Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors

Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors

From:: Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: